(1)
Phansenee, S.; Angkatavanich, T.; Rittiluechai, K.; Intharaburan, S. Incidence of Cardiotoxicity Associated with The Use of Pegylated Liposomal Doxorubicin in Gynecologic Malignancies. BSCM 2024, 63, 229-233.